Thromboxane A2 receptors: Where have you gone?

Prostaglandins and Other Lipid Mediators

Volumn 60, Issue 4-6, 2000, Pages 175-189

  Halushka, Perry V ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Thromboxane A2; Thromboxane receptors

Indexed keywords

ACETYLSALICYLIC ACID; AMINO ACID; ANDROGEN; ARGININE; CYSTEINE; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTIDINE; RECEPTOR SUBTYPE; SERINE; TESTOSTERONE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PROSTAGLANDIN METABOLISM; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SECOND MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0034037318     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(99)00062-3     Document Type: Review

References (112)

1. Coleman RA, Smith WL, Narumiya S. VIII. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-29.
2. 2 its generation and role in platelet activation . Prog Lipid Res. 28:1989;273-301.
3. 2 receptor antagonists. Adv Drug Res. 25:1994;173-202.
4. 2 receptors. J Lipid Mediators Cell Signal. 12:1995;361-378.
5. 2, and other eicosanoids. Von Bruchhusen F., Walter U. Handbook of Experimental Pharmacology, Platelets, and their Factors. 1997;459-482 Springer-Verlag, Berlin.
6. Hamberg M., Svensson J., Samuelsson B. Thromboxanes a new group of biologically active compounds derived from prostaglandin endoperoxides . Proc Natl Acad Sci USA. 72:1975;2994-2998.
7. Fitzgerald D.J., FitzGerald G.A. Eicosanoids in myocardial ischemia and injury. Halushka P.V., Mais D.E. Advances in Eicosanoid Research. 1988;128-158 MTP Press, Norwell, MA.
8. 2 receptors. Trends Cardiovas Med. 1:1991;157-161.
9. Patrono C. Aspirin as an antiplatelet drug. New Eng J Med. 330:(18):1994;1287-1294.
10. Halushka P.V., Mais D.E., Mayeux P.R., Morinelli T. Prostaglandin, thromboxane and leukotriene receptors. Annu Rev Pharmacol Toxicol. 29:1989;213-239.
11. 2 stimulated mitogenesis of coronary artery smooth muscle cells involves activation of MAP kinase and S6 kinase. J Biol Chem. 269:(8):1993;5693-5698.
12. Craven P.A., Studer R.K., DeRubertis F.R. Thromboxane/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-β Hypertension. 28:(2):1996;169-176.
13. 2 and vascular smooth muscle cell proliferation. Hypertension. 26:1995;771-780.
14. 2 modulates the fibrinolytic system in glomerular mesangial cells. Am J Physiol. 275:1998;F262-F269.
15. Bruggeman L.A., Horigan E.A., Horikoshi S., Ray P.E., Klotman P.E. Thromboxane stimulates synthesis of extracellular matrix proteins in vitro. Am J Physiol. 261:1991;F488-F494.
16. 2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins. 44:1992;155-163.
17. Ballesteros J.M., Weinstein H. Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors. Meth Neurosci. 25:1995;366-428.
18. 2α are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 87:1990;9383-9387.
19. 2α, is formed in vivo. Biochim Biophys Acta. 1210:1994;244-248.
20. 2α. Ann N Y Acad Sci USA. 744:1994;139-145.
21. 2 receptors. J Biol Chem. 273:1998;475-483.
22. 2 receptor high affinity for the agonist ligand I-BOP . Prostaglandins. 52:1996;303-316.
23. 2 receptor from rat astrocytes. Biochim Biophys Acta. 1265:1995;220-223.
24. Abe T., Takeuchi K., Takahashi N., Tsutsumi E., Taniyama Y., Abe K. Rat kidney thromboxane receptor molecular cloning, signal trandsuction, and intrarenal expression localization . J Clin Invest. 96:1995;657-664.
25. 2 receptor cDNA, cloning, expression and Northern blot analysis . Biochim Biophys Res Comm. 184:1992;1197-1203.
26. 2 receptor. Nature. 349:1991;617-620.
27. 2 receptor gene in human uterus. 1992;47:105-17.
28. 2 receptors evidence for different subclasses in the rat . Biochem Pharmacol. 42:1991;537-544.
29. Brown G.P., Venuto R.C. Thromboxane receptors in human kidney tissues. Prostaglandins Lipid Mediators. 57:1999;179-188.
30. 2 receptor gene. Biochem Biophys Res Commun. 256:1999;391-397.
31. 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J Exp Med. 178:1993;1825-1830.
32. 2. J Pharmacol Exp Therap. 270:1994;446-452.
33. LeDuc L.E., Wyche A.A., Sprecher H., Sankarappe S.K., Needleman P. Analogues of arachidonic acid used to evaluate structural determinants of prostaglandin receptor and enzyme specificities. Mol Pharmacol. 19:1981;242-247.
34. Lefer A.M., Smith E., Araka H., et al. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci USA. 77:1980;1706-1710.
35. 2 analogs in platelets and blood vessels. Eur J Pharmacol. 148:1988;309-315.
36. 2 antagonists on platelets and veins. Eur J Pharmacol. 111:1985;125-128.
37. 2 analogue (U46619), on human platelets. Am J Physiol. 253:1987;H1035-H1043.
38. 2 with differential effects on platelets and blood vessels . Proc Natl Acad Sci USA. 86:1989;5600-5604.
39. 2 receptor subtypes. J Clin Invest. 84:1989;1883-1891.
40. 2 receptor. Adv Prostaglandin, Thromboxane, Leukot Res 1990;20:102-9.
41. 2 receptors in cultured rat aortic smooth muscle cells. Circ Res. 69:1991;638-643.
42. 2 receptors in human vascular smooth muscle cells. Life Sci. 46:1990;1765-1772.
43. 2 receptor agonist. J Pharmacol Exp Ther. 251:1989;557-562.
44. 2 receptors. Am J Physiol. 260:1991;H327-H334.
45. 2 receptors using structurally different antagonists. Eur J Pharmacol. 152:1988;311-319.
46. 2 receptors in the pig. Eur J Pharmacol. 160:1989;313-321.
47. 2 receptors in platelets and cultured aortic smooth muscle cells. Biochem Pharmacol. 38:1989;2967-2976.
48. 2 receptor gene. J Biol Chem. 268:1993;25253-25259.
49. 2 receptor (TBXA2R) to chromosome 19p13. 3 using transcribed 3′ untranslated DNA sequence polymorphisms. Genomics. 18:1993;212-215.
50. 2. J Clin Invest. 102:1998;1994-2001.
51. 2 receptor. J Biol Chem. 269:(30):1994;19256-19261.
52. 60 to Leu mutation. J Clin Invest. 97:1996;949-956.
53. 2 recetor subtypes. Circ Res. 80:1997;551-556.
54. 13 effect on ligand binding and signaling . Biochim et Biophys Acta. 1450:1999;288-296.
55. 2+ mobilization in human platelets stimulated by ADP, and the thromboxane mimetic U46619. J. Biol Chem. 264:1990;719-725.
56. 2 receptor agonists. Thrombosis Res. 64:1991;667-676.
57. 2 receptors . J Leukocyte Biol. 53:1993;173-178.
58. 2 receptors. J Biol Chem. 273:1998;22753-22760.
59. i2 in phospholipid vesicles. Molecular Pharmacol. 46:1994;808-816.
60. 2 stimulated signal transduction in vascular smooth muscle. J Pharmacol Exp Therap. 265:1993;447-456.
61. Dorn G.W. II, Becker M.W., Davis M.G. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem. 267:1992;1-9.
62. 2 mimetic I-BOP in A7r5 cells. Biochem Pharmacol. 53:1997;1-10.
63. Saklatvala J., Rawlinson L., Waller R.J., et al. Role for p38 mitogen-activated protein kinase in platelet aggregaton caused by collagen or a thromboxane analogue. J Biol Chem. 271:1996;6586-6589.
64. Ca channel activity from pig coronary artery. Am J Physiol 1992;C708-13.
65. 2 receptor-mediated contraction in rat aorta. J Pharmacol Exp Therap. 284:1998;921-928.
66. 2 receptor in human platelets is a member of the novel Gq family. J Biol Chem. 266:1991;9309-9313.
67. 2 receptors. J Biol Chem. 268:1993;26011-26017.
68. 2α. J Pharmacol Exp Therap. 281:1997;957-964.
69. 2 and thrombin receptors in human platelets. Proc Natl Acad Sci. 91:1994;504-508.
70. 2 receptors. J Biol Chem. 274:1999;14325-14330.
71. 13. J Biol Chem 1999;274:28003-10.
72. Rosenblum W.I., El-sabban F., Nelson G.H., Allison T.B. Effects in mice of testosterone and dihydrotestosterone on platelet aggregation in injured arterioles and ex vivo. Thromb Res. 45:1987;719-728.
73. Voyno-Yasenetskaya T., Conklin B.R., Gilbert R.L., Hooley R., Bourne H.R., Barber D.L. Gα13 stimulates Na-H exchange. J Biol Chem. 269:1994;4721-4724.
74. h (transglutaminase II)-mediated signaling. J Biol Chem. 271:1996;16451-16454.
75. Hwang K.-C., Gray C.D., Sivasubramanian N., Im M.J. Interaction Site of GTP Binding Gh (Transglutaminase II) with phospholipase C. J Biol Chem. 270:1995;27058-27062.
76. h. J Biol Chem. 274:1999;12774-12779.
77. 16 couple a wide variety of receptors to phospholipase C. J Biol Chem. 270:1995;15175-15180.
78. Djellas Y., Antonakis K., LeBreton G.C. A molecular mechanism for signaling between seven-transmembrane receptors evidence for a redistribution of G proteins . Proc Natl Acad Sci. 95:1998;10944-10948.
79. q . J Pharmacol Exp Therap. 277:1996;1132-1139.
80. 1A receptor. Biochemistry. 33:1994;4283-4290.
81. 1A receptor in Sf9 cells. J Biol Chem. 270:(31):1995;18691-18699.
82. 3 determines G-protein specificity. Nature. 365:1993;166-170.
83. 3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur J Biochem. 217:1993;313-318.
84. o. J Biol Chem. 268:(35):1993;26067-26070.
85. s through interaction of α-carboxylic acid of agonist and arginine residue of seventh transmembrane domain. J Biol Chem. 270:1995;16122-16127.
86. Spengler D., Waeber C., Pentaloni C., et al. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:1993;170-175.
87. Costa T., Lang J., Gless C., Herz A. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes specific regulation by antagonists and sodium ions . Mol Pharmacol. 37:1990;383-394.
88. 2-adrenergic receptor activation of G proteins evidence for a precoupled receptor/G protein state . Molec Pharmacol. 45:1994;524-531.
89. 2-adrenergic receptor. Mol Pharmacol. 45:1994;390-394.
90. 2 receptors by the mimetic U46619. J Pharmacol Exp Therap. 247:(3):1988;1133-1138.
91. 2 receptors. J Pharmacol Exp Ther. 262:1992;238-245.
92. 2 receptors. Biochim Biophys Acta. 1221:1994;83-88.
93. 2 receptor desensitization. J Biol Chem. 265:1990;21670-21675.
94. 2 in CHRF-288 megakaryocytic cells. Am J Physiol 1992;262:C991-9.
95. 2 Receptor α and β Isoforms: role of the differentially spliced COOH terminus in agonist-promoted receptor. J Biol Chem 1999;274:8941-8.
96. 2 receptors in cultured human chronic myelogenous leukemia (K562) cells. J Pharmacol Exp Therap. 259:1991;228-234.
97. 2 receptor. J Biol Chem. 269:1994;29914-29919.
98. Studer R.K., Craven P.A., DeRubertis F.R. Activation of protein kinase C reduces thromboxane receptors in glomeruli and mesangial cells. Kidney Intl. 44:1993;58-64.
99. Habib A., Vezza R., Creminon C., Maclouf J., FitzGerald G.A. Rapid, agonist-dependent phosphorylation in vivo of human thromboxane receptor isoforms; minimal involvement of protein kinase C. J Biol Chem. 272:1997;7191-7200.
100. Spurney R.F., Coffman T.M. The C terminus of the thromboxane receptor contributes to coupling and desensitizaton in a mouse mesangial cell line. J Pharmacol Exp Therap. 283:1997;207-215.
101. Wang G.-R., Zhu Y., Halushka P.V., Lincoln T.M., Mendelsohn M.E. Mechanism of platelet inhibition by nitric oxide in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase . Proc Natl Acad Sci. 95:1998;4888-4893.
102. 2 receptor agonist and antagonist binding in human platelets. J Biol Chem. 266:1991;13752-13758.
103. 2 receptor allows discrimination between agonist and antagonist binding sites. Mol Pharmacol. 44:1993;934-939.
104. Dorn G.W.I., Davis M.G., D'Angelo D.D. Structural determinants for agonist binding affinity to thromboxane/prostaglandin endoperoxide (TP) receptors. Analysis of chimeric rat/human receptors. J Biol Chem. 272:1997;12399-12405.
105. 2 receptor and analysis of the receptor-ligand interaction. J Med Chem. 36:1993;820-825.
106. 2 receptor in insect cells. Arch Biochem Biophys. 334:(1):1996;9-17.
107. Strader C.D., Sigal I.S., Register R.B., Candelore M.R., Rands E., Dixon R. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc Natl Acad Sci. 84:1987;4384-4388.
108. Strader C.D., Sigal I.S., Dixon R.A. Structural basis of β-adrenergic receptor function. FASEB J. 3:1989;1825-1832.
109. 2 receptor binding. Biochemical Pcol 1994;49:921-7.
110. D'Angelo D.D., Eubank J.J., Davis M.G., Dorn G.W. II. Mutagenic analysis of platelet thromboxane receptor cysteines. J Biol Chem. 271:1996;6233-6240.
111. 2 receptor density and aggregation responses. Circulation. 91:1995;2742-2747.
112. Rockhold R.W. Cardiovascular toxicity of anabolic steroids. Am Rev Pharmacol Toxicol. 33:1993;497-520.